Trial Profile
Investigation on efficacy and safety of rivastigmin patch in patients switched from donepezil with mild to moderate Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 03 Dec 2018 Status changed from recruiting to completed.
- 08 Jun 2013 New trial record